SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C.
         CORRECTED COPY

         Litigation Release No.  15843A /  August 12, 1998

         SEC v. ALEJANDRO C. ZAFFARONI, EUGENE FARBER, NICOLAS VIDA,
         ALBA ROSA ARZATE, YOLANDA ROCCO, INES ROMERO, AND PEDRO
         ZAFFARONI, Civil Action No. C-98 20843 (JW) (N.D. Cal. Aug.
         12, 1998)

              The Securities and Exchange Commission announced today
         that it filed an insider trading action against Alejandro C.
         Zaffaroni, the founder and former chief executive officer of
         Affymax N.V., ("Affymax"), and against six other defendants.
         The Complaint charges that Zaffaroni violated the securities
         laws by communicating information about the January 1995
         acquisition of Affymax by Glaxo plc to three friends and to
         certain family members in Uruguay.  Zaffaroni's friends and
         family members profited by purchasing Affymax securities
         before the acquisition was publicly announced.  At the time
         of the trading, Affymax, a drug discovery company located in
         Palo Alto, California, and pharmaceutical giant Glaxo plc
         (now Glaxo Wellcome plc) were engaged in confidential
         negotiations that resulted in Glaxo's acquisition of Affymax
         in a friendly tender offer.

              Simultaneous with the filing of the Complaint each of
         the defendants, without admitting or denying the allegations
         in the Complaint, consented to the entry of Final Judgments
         permanently enjoining them from violating the insider
         trading prohibitions contained in Section 14(e) of the
         Securities Exchange Act of 1934 ("Exchange Act") and Rule
         14e-3 thereunder, and ordering them to disgorge profits and
         to pay penalties on the trading.  Section 14 (e) and Rule
         14e-3 prohibit communicating or trading on inside
         information in connection with a tender offer.  Zaffaroni
         has also consented to an injunction enjoining him from
         future violations of Section 10 (b) of the Exchange Act and
         Rule 10b-5 thereunder.

              In addition to the entry of injunctions, six of the
         seven defendants have agreed to pay a total of $1,849,953 in
         penalties, disgorgement of profits, and interest, as
         follows:

              Zaffaroni, of Atherton, California, will pay a civil
                penalty of $552,021.

              Eugene Farber, of Portola Valley, California, will pay
                $230,510, which includes disgorgement and prejudgment
                interest of $132,510 and a penalty of $98,000.

              Nicholas Vida, of San Mateo, California will pay
                $83,501, which includes disgorgement and prejudgment
                interest of $48,001 and a penalty of  $35,500.

              Alba Rosa Arzate, of Mexico City, Mexico, will pay
                $165,809, which includes disgorgement and prejudgment
                interest of $95,316 and a penalty of $70,493.

              Pedro Zaffaroni, of Montevideo, Uruguay, will pay
                $746,973, which includes disgorgement and prejudgment
                interest of $429,402 and a penalty of $317,571.

              Ines Romero, of Montevideo, Uruguay, will pay $71,639,
                which includes disgorgement and prejudgment interest
                of $41,182 and a penalty of $30,457.

              The Commission's Complaint alleges that Zaffaroni's
         friends, Farber, Vida and Arzate purchased large blocks of
         Affymax shares in the two weeks preceding the Glaxo tender
         offer announcement following meetings or telephone calls
         with Zaffaroni.  During the same period, Zaffaroni told a
         family member living in Uruguay that he was in the final
         stages of selling Affymax. At the time of the trading,
         Zaffaroni was CEO and a member of the board of directors of
         Affymax.  After learning of the acquisition, Zaffaroni's
         nephew and niece, Pedro Zaffaroni and Ines Romero, and
         Zaffaroni's former sister-in-law, Yolanda Rocco, all of whom
         live in Uruguay, purchased Affymax shares before the tender
         offer's announcement.  The Commission's Complaint also
         alleges that Pedro Zaffaroni used four nominees to buy
         Affymax shares and that he passed news of the acquisition to
         two others, resulting in trading profits by the Zaffaroni
         family and friends of the Zaffaroni family in Uruguay of
         approximately $348,000.